XOMA Royalty Corp. (XOMA)
NASDAQ·Healthcare·Biotechnology
$40.94
-2.45%
Mkt Cap $451.61M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $11.05M | $13.76M | +24.50% | -$0.13 | $0.12 | +192.31% | — | — |
| Q4 2025 Nov 12, 2025 | $11.13M | $9.35M | -15.98% | -$0.02 | -$0.35 | -1650.00% | — | — |
| Q3 2025 Aug 13, 2025 | $9.92M | $13.13M | +32.32% | -$0.12 | $0.48 | +500.00% | — | — |
| Q2 2025 May 13, 2025 | $7.07M | $15.91M | +125.22% | -$0.26 | $0.06 | +123.08% | — | — |
| Q1 2025 Mar 17, 2025 | $8.75M | $2.34M | -73.22% | -$0.29 | -$0.46 | -58.62% | — | — |
| Q4 2024 Nov 7, 2024 | $8.75M | $7.20M | -17.72% | -$0.44 | -$0.39 | +11.36% | — | — |
| Q3 2024 Aug 13, 2024 | $8.38M | $11.09M | +32.29% | -$0.26 | -$0.28 | -7.69% | — | — |
| Q2 2024 May 9, 2024 | $1.33M | $1.49M | +12.03% | -$0.71 | -$0.86 | -21.13% | — | — |
| Q1 2024 Mar 8, 2024 | $3.60M | $1.83M | -49.08% | -$0.36 | -$0.49 | -36.11% | — | — |
| Q4 2023 Nov 7, 2023 | $3.60M | $830.00K | -76.94% | -$0.48 | -$0.60 | -25.00% | — | — |
| Q3 2023 Aug 8, 2023 | $800.00K | $1.66M | +107.25% | -$0.52 | -$0.59 | -13.46% | — | — |
| Q2 2023 May 9, 2023 | $760.00K | $437.00K | -42.50% | -$0.50 | -$0.98 | -96.00% | — | — |
| Q1 2023 Mar 9, 2023 | $1.06M | $1.49M | +40.19% | $0.47 | -$0.64 | -236.17% | — | — |
| Q4 2022 Nov 3, 2022 | $4.52M | $451.00K | -90.02% | -$0.20 | -$0.48 | -140.00% | — | — |
| Q3 2022 Aug 4, 2022 | $4.27M | $983.00K | -76.98% | -$0.11 | -$0.53 | -381.82% | — | — |
| Q2 2022 May 5, 2022 | $3.17M | $3.11M | -1.83% | -$0.34 | -$0.32 | +5.88% | — | — |
| Q1 2022 Mar 8, 2022 | $35.14M | $35.94M | +2.29% | $2.27 | $1.67 | -26.43% | — | — |
| Q4 2021 Nov 4, 2021 | $2.59M | $940.00K | -63.71% | -$0.09 | -$0.51 | -466.67% | — | — |
| Q3 2021 Aug 5, 2021 | $2.11M | $901.00K | -57.30% | -$0.41 | -$0.31 | +24.39% | — | — |
| Q2 2021 May 6, 2021 | $801.56K | $375.00K | -53.22% | -$0.15 | -$0.70 | -366.67% | — | — |